采用中药健脾消癌饮加化疗治疗大肠癌术后 40例 ,并与单纯化疗 40例进行对比。结果 :1、3、5年生存率中药加化疗组分别为 92 .5 %、77.5 %、6 7.5 % ,单纯化疗组为 90 .0 %、6 2 .5 %、45 .0 % (P<0 .0 5 )。同时显示中医药在大肠癌术后巩固治疗中 ,能改善患者临床症状 ,提高生活质量和免疫机能 ,降低癌胚抗原含量 ,并能减轻化疗毒副反应 ,减少术后复发、转移率 The traditional Chinese medicine Jianpi Xiaogan Yin and chemotherapy was used to treat 40 cases of colorectal cancer, and compared with 40 cases of chemotherapy alone. Results: The 1-, 3-, and 5-year survival rates of the traditional Chinese medicine plus chemotherapy group were 92.5%, 77.5%, and 6.7.5%, respectively, and the chemotherapy alone group was 90.0 %, 62.5%, and 45.0% (P< 0 .0 5 ). At the same time, it is shown that TCM can improve clinical symptoms, improve the quality of life and immune function, reduce the content of carcinoembryonic antigen, and reduce the side effects of chemotherapy and reduce postoperative recurrence and metastasis.